Search results
Two Philadelphia-area biotech firms report progress on pursuit of a hepatitis B cure - Philadelphia...
The Business Journals· 3 days agoTwo local life sciences companies reported progress this week on their efforts to develop a cure for...
Magistrate Sides With Defendants in Inmate's Claims in Failure to Treat Hep C | Law.com
Law.com· 6 days agoIn a memorandum opinion and recommendation issued May 28, Auld found that physician assistant Karen...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 3 days agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus - Atea...
Benzinga· 4 days agoAtea Pharmaceuticals Inc AVIR announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis ...
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress...
The Tomahawk· 2 days agoNew translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection
Cost and Vosevi: How to find savings, lower costs, and more
Medical News Today· 6 days agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
Humans and Neanderthals only had sex for a brief period, but it still fundamentally changed our DNA
Business Insider via Yahoo News· 2 days agoOther studies have linked Neanderthal genes to autoimmune diseases and diabetes. On the other hand,...
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Zacks· 2 days agoThis change outpaced the S&P 500's 0.11% loss on the day. Heading into today, shares of the HIV and hepatitis C drugmaker had lost 1.13% over the past month ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoWith an 8-week treatment duration, the Phase 2 data from the lead-in cohort of non-cirrhotic patients showed a 97% sustained virologic response rate at 12 weeks post-treatment (SVR12), which ...
From syphilis to gonorrhea, WHO flags ‘major increase’ in STIs worldwide
San Francisco Chronicle· 6 days agoEvery day, more than 1 million people are infected by chlamydia, gonorrhea, syphilis or trichomoniasis, leading to 2.5 million deaths each year. Within the United States, Georgia ranked fifth ...